The Medicines (Fees Relating to Medicinal Products for Animal Use) Regulations 1994

Interpretation

2.—(1) In these Regulations, unless the context requires otherwise—

“the Act” means the Medicines Act 1968(1);

“biological medicinal product” includes an antigen, toxin, antitoxin, toxoid, serum, antiserum or vaccine or a fraction of any such product;

“emergency vaccines” means vaccines manufactured or assembled only from material obtained from the particular animal, flock or herd intended to be vaccinated in circumstances in which no other suitable licensed vaccines are readily available for such use;

“medicinal product” includes any substance or article specified in any Order made under

(a)

section 104 or 105(1)(a) of the Act which directs that Part II of the Act shall have effect in relation to such substance or article; or

(b)

section 130(3A) of the Act(2) which provides that such substance or article shall be treated as a medicinal product,

and includes any substance or article to be administered in a medicinal test on animals under section 32(6)(c) of the Act.

(2) In these Regulations, unless the context otherwise requires, any reference to a regulation or a Schedule is a reference to a regulation of or Schedule to these Regulations, and any reference in a regulation or a Schedule or Part of a Schedule to a paragraph is a reference to a paragraph of the regulation or Schedule or Part of a Schedule.

(1)

1968 c. 67.

(2)

Section 130 was extended by section 13(2) Animal Health and Welfare Act 1984 (c. 40).